Alchemab receives funding boost for Parkinson’s research
Innovative antibody discovery could lead to new Parkinson’s treatments
Read More
Tag: Funding
CellVoyant secures £7.6 million AI stem cell boost
CellVoyant’s platform combines AI with live cell imaging
Read More
GeneCode receives record Parkinson’s funding
European Innovation Council Accelerator finances treatment development drive for condition
Read More
Anoat Therapeutics receives cystic fibrosis funding boost
Vital financing will be used to develop novel therapies for condition with high unmet medical need
Read More
Scarlet Therapeutics gains funding for blood cell platform
Vital financing will allow the company to build a pipeline of novel therapies targeting serious conditions
Read More
Adcendo funding boosts antibody-drug conjugates development
Funds will be used to ensure the wider pan-sarcoma development of lead candidate uPARAP
Read More
Clinical trial transformation funds for Aberdeen scientist
Dr Beatriz Goulao receives more than £500,000 to make trials more patient-focused
Read More
Vitestro raises vital funding for autonomous blood drawing device
Company raises €12m in financing with a view to entering to the European market
Read More
Vital funding established for Evonetix projects
Financing will allow company’s development of DNA synthesis chip technology to commercial scale
Read More
Iconovo receives $883,800 grant from the Bill & Melinda Gates Foundation
Funding will develop inhaled therapies using ICOone Nasal in preparation for the next pandemic
Read More
NHS leaders facing real-terms reduction in funding
Difficult choices loom regarding which areas of patient care to cut back
Read More
NRG receives £2.68m funding boost for neurodegenerative disorders
NRG Therapeutics announces multi-million Innovate UK Award to develop treatments for Parkinson’s and motor neurone disease
Read More
- MHRA approves new treatment for severe alopecia areata
- Aplagon doses first patient in phase 2a trial of APAC
- NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats
- UCB reports superiority of bimekizumab in psoriatic arthritis study
- Kainova reports positive results for DT‑9081 in advanced solid tumours
